ArticleJournal of experimental & clinical cancer research : CR2019

Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells.

Fujun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.